Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients

Polish Journal of Pharmacology

Volumn 48, Issue 3, 1996, Pages 327-329

  Dmoszyńska, Anna ^a   Janicki, Krzysztof ^a   Janicka, Lucyna ^a   Przesmycki, Krzysztof ^a   Sokołowska, Bozena ^a   Walter Croneck, Adam ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Arteriovenous fistula; Indobufen; Peritoneal dialysis; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; INDOBUFEN; MALONALDEHYDE; THROMBOCYTE FACTOR 3; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTERIOVENOUS FISTULA; BLEEDING TIME; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; PERITONEAL DIALYSIS; TERMINAL DISEASE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

ADENOSINE DIPHOSPHATE; ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; BLEEDING TIME; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PHENYLBUTYRATES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FACTOR 3; THROMBOSIS;

EID: 0029814704     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Born G. V. R.: Aggregation of blood platelets by adenosine diphosphate. Nature, 1962, 104, 927.
2. Breddin K., Grun H., Krzywanek H. R.: On the measurement of spontaneous platelet aggregation: platelet aggregation test III. Methods and first clinical results. Thromb. Haemost., 1976, 35, 669-691.
3. Ciavarella N.: The effect of indobufen (k 3920) on platelet aggregation, platelet factor 3, 4 and some coagulation parameters in patients with venous thrombosis. Curr. Ther. Res, 1981, 29, 503-508.
4. Janicki K., Janicka L., Dmoszyńska A., Marczewski K., Smarz I.: Effects of ticlopidine on platelet activity and occlusion of arteriovenous fistulas in IPD patients. Dialysis Transplant., 1994, 23, 576-579.
5. Komarnicki M., Pietrzak I.: Mechanisms of platelet aggregation disturbances and their relation to treatment in patients with chronic uremia. Int. J. Artif. Organs., 1988, II, 67-70.
6. Lindsay R. M., Friesen M., Koens F., Linton A. L., Oreopoulos D. G., de Veber A.: Platelet function in patients on long-term peritoneal dialysis. Clin. Nephrol., 1976, 6, 335-339.
7. Mannucci L., Maderna P., Colli S., Lavezzari M., Sirtori C. R., Tremoli E.: Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk. Thromb. Res., 1987, 48, 417-426.
8. Mennes P. A., Gilula L. A., Anderson C. B.: Complication associated with arteriovenous fistulas in patients undergoing chronic hemodialysis. Arch. Intern. Med., 1978, 139, 1117-1121.
9. Mielke C. H.: Template bleeding time: technique. In: Platelet function testing. DHEW Publications No. (NIH) 78-1087, 1977, 723.
10. Nenci C. G., Berrettini M., Agnelli G., Parise P., Buoncristiari U., Ballatori E.: Effect of peritoneal dialysis, hemodialysis, and kidney transplantation on blood platelet function. 1. Platelet aggregaton by ADP and epinephrine. Nephron, 1979, 23, 287-292.
11. O'Brien J. R., Etherington M. D.: Heparin - thrombin clotting time and platelet factor 4. Lancet, 1974, 2, 924.
12. Saleem A., Krieg A., Cieslica R.: Platelet activity ratio. Amer. J. Clin. Pathol., 1975, 232, 1303.
13. Stuart M. J.: Platelet malondialdehyde formation. An indicator of platelet hyperfunction. Thromb. Haemost., 1979, 42, 649.
14. Tobelem G.: Antiplatelet agents, a therapy that is gaining ground. Sang. Thrombose Vaisseaux, 1990, 3-5.
15. Tremoli E., Maderna P., Sirtori M., Colli S., Corvi G., Sirtori C. R.: Indobufen treatment in type lia hypercholesterolemic subjects: effects on platelet function and malondialdehyde production. Pharmacol. Res. Commun., 1981, 13, 847-859.
16. Wu K. K., Hoak J. C.: A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet, 1974, 2, 924.